Stoke Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. 

CEO
Ian Frederick Smith
CEOIan Frederick Smith
Employees
128
Employees128
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2014
Founded2014
Employees
128
Employees128

STOK Key Statistics

Market cap
721.77M
Market cap721.77M
Price-Earnings ratio
15.70
Price-Earnings ratio15.70
Dividend yield
Dividend yield
Average volume
523.02K
Average volume523.02K
High today
$14.50
High today$14.50
Low today
$12.49
Low today$12.49
Open price
$12.93
Open price$12.93
Volume
1.54M
Volume1.54M
52 Week high
$16.15
52 Week high$16.15
52 Week low
$5.35
52 Week low$5.35

STOK News

TipRanks 1d
Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome

Stoke Therapeutics ((STOK)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.